NCT04030832

Brief Summary

The etiology of non-healing ulcers depends on both systemic and local factors. The introduction of advanced dressing, negative wound therapy and compression therapy have undoubtedly improved clinical outcomes. The principal aim of study was to demonstrate the efficacy of skin micrografts in the treatment of skin substance loss.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2017

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2017

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2018

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2019

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

July 17, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 24, 2019

Completed
Last Updated

July 24, 2019

Status Verified

July 1, 2019

Enrollment Period

1 year

First QC Date

July 17, 2019

Last Update Submit

July 23, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Wound Bed Score values

    Percentage of patients with change of the Wound Bed Score values higher than 50%, after 30 days,

    change of baseline wound bed score values at day 30

Secondary Outcomes (2)

  • Spontaneous re-epithelialization.

    Day 0 and Day 30

  • Vancouver scale

    Day 30, Day 90 and Day 180

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients who attend the various regional hospitals through the emergency room or surgical clinic

You may qualify if:

  • Full-thickness skin loss from a minimum size of 3x3 cm (9cm2) to a maximum size of 5x5 cm (25cm2);
  • Loss of substance caused by abrasive-contusive traumas (loss of full-thickness skin substance) or by thermal burn (deep degree II), present for at least 15 days;
  • Absence of clinical signs of infection assessed by two culture swabs performed at T0 (pre and post debridement);
  • Pre-operative inflammatory index (VES, PCR) and b-hcg negative;
  • Absence of exposure of osteo-cartilaginous structures, of noble structures (major arterial vessels, major nerve trunks, tendons without paratenon);
  • Specific written informed consent

You may not qualify if:

  • Smoking patients (≥ 10 cigarettes / day);
  • Patients with type I or type II diabetes mellitus:
  • Patients suffering vascular trophic ulcers;
  • Patients with loss of substance at the level of the fingers and toes;
  • Patients with loss of substance of the foot and the yarrow region;
  • Patients with oncological pathologies in progress or in remission;
  • Patients in therapy with immunosuppressive and corticosteroid drugs, anticoagulants, antiplatelet agents;
  • Patients with autoimmune diseases including connectivitis;
  • Patients with congenital, acquired and metabolic immunodeficiencies;
  • Pregnant patients (ascertained with β-HCG) and breastfeeding.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Azienda Ospedaliera Universitaria Ospedali Riuniti

Ancona, AN, 60126, Italy

Location

IRCCS Policlinico San Donato

Milan, MI, Italy

Location

Università degli Studi di Udine

Udine, UD, Italy

Location

Università degli Studi di Roma "La Sapienza"

Roma, Italy

Location

Related Publications (10)

  • Greaves NS, Ashcroft KJ, Baguneid M, Bayat A. Current understanding of molecular and cellular mechanisms in fibroplasia and angiogenesis during acute wound healing. J Dermatol Sci. 2013 Dec;72(3):206-17. doi: 10.1016/j.jdermsci.2013.07.008. Epub 2013 Jul 30.

  • Trovato L, Monti M, Del Fante C, Cervio M, Lampinen M, Ambrosio L, Redi CA, Perotti C, Kankuri E, Ambrosio G, Rodriguez Y Baena R, Pirozzi G, Graziano A. A New Medical Device Rigeneracons Allows to Obtain Viable Micro-Grafts From Mechanical Disaggregation of Human Tissues. J Cell Physiol. 2015 Oct;230(10):2299-303. doi: 10.1002/jcp.24973.

  • Marcarelli M, Trovato L, Novarese E, Riccio M, Graziano A. Rigenera protocol in the treatment of surgical wound dehiscence. Int Wound J. 2017 Feb;14(1):277-281. doi: 10.1111/iwj.12601. Epub 2016 Apr 29.

  • Baglioni E, Trovato L, Marcarelli M, Frenello A, Bocchiotti MA. Treatment of Oncological Post-surgical Wound Dehiscence with Autologous Skin Micrografts. Anticancer Res. 2016 Mar;36(3):975-9.

  • Svolacchia F, De Francesco F, Trovato L, Graziano A, Ferraro GA. An innovative regenerative treatment of scars with dermal micrografts. J Cosmet Dermatol. 2016 Sep;15(3):245-53. doi: 10.1111/jocd.12212. Epub 2016 Jan 30.

  • De Francesco F, Graziano A, Trovato L, Ceccarelli G, Romano M, Marcarelli M, Cusella De Angelis GM, Cillo U, Riccio M, Ferraro GA. A Regenerative Approach with Dermal Micrografts in the Treatment of Chronic Ulcers. Stem Cell Rev Rep. 2017 Feb;13(1):139-148. doi: 10.1007/s12015-016-9692-2.

  • Falanga V, Saap LJ, Ozonoff A. Wound bed score and its correlation with healing of chronic wounds. Dermatol Ther. 2006 Nov-Dec;19(6):383-90. doi: 10.1111/j.1529-8019.2006.00096.x.

  • Qi X, Ding L, Huang W, Wen B, Guo X, Zhang J. An improved automated type-based method for area assessment of wound surface. Wound Repair Regen. 2017 Jan;25(1):150-158. doi: 10.1111/wrr.12495. Epub 2017 Jan 25.

  • Baryza MJ, Baryza GA. The Vancouver Scar Scale: an administration tool and its interrater reliability. J Burn Care Rehabil. 1995 Sep-Oct;16(5):535-8. doi: 10.1097/00004630-199509000-00013.

  • Jimi S, Kimura M, De Francesco F, Riccio M, Hara S, Ohjimi H. Acceleration Mechanisms of Skin Wound Healing by Autologous Micrograft in Mice. Int J Mol Sci. 2017 Aug 2;18(8):1675. doi: 10.3390/ijms18081675.

MeSH Terms

Conditions

Skin UlcerAccidental Injuries

Condition Hierarchy (Ancestors)

Skin DiseasesSkin and Connective Tissue DiseasesWounds and Injuries

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

July 17, 2019

First Posted

July 24, 2019

Study Start

October 1, 2017

Primary Completion

October 1, 2018

Study Completion

June 30, 2019

Last Updated

July 24, 2019

Record last verified: 2019-07

Locations